Prelude Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Prelude Capital Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,000	Closed	-$146K	–	1879
2017 Q4	$146K	Buy	+6,000	New	+$115K	0.01%	696

Prelude Capital Management's ENTL Position: Q1 2018 in Review

Prelude Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 5,110 shares — an estimated $125K sold.

Prelude Capital Management first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $125K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Prelude Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Prelude Capital Management sold 5,110 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $125K.
Prelude Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Prelude Capital Management's Entellus Medical, Inc. Common Stock position peaked at $125K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.